All Updates

All Updates

icon
Filter
Partnerships
Midi Health partners with Neurotrack to screen for cognitive conditions in menopausal women
Preventive Healthcare
Mar 25, 2024
This week:
Product updates
Hexagon unveils Advanced Compensation for metal 3D printing
Additive Manufacturing
Yesterday
Funding
Eden AI raises EUR 3 million in seed funding to accelerate product development
Generative AI Infrastructure
Nov 21, 2024
M&A
Wiz acquires Dazz to expand cloud security remediation capabilities
Next-gen Cybersecurity
Nov 21, 2024
Partnerships
Immutable partners with Altura to enhance Web3 game development and marketplace solutions
Web3 Ecosystem
Nov 21, 2024
Funding
OneCell Diagnostics raises USD 16 million in Series A funding to enhance cancer diagnostics
Precision Medicine
Nov 21, 2024
Partnerships
BioLineRx and Ayrmid partner to license and commercialize APHEXDA across multiple indications
Precision Medicine
Nov 21, 2024
Product updates
SOPHiA GENETICS announces global launch of MSK-IMPACT powered with SOPHiA DDM
Precision Medicine
Nov 21, 2024
Product updates
Biofidelity launches Aspyre Clinical Test for lung cancer detection
Precision Medicine
Nov 21, 2024
Partnerships
Spendesk partners with Adyen to enhance SMB spend management with banking-as-a-service solution
Business Expense Management
Nov 21, 2024
M&A
Mews acquires Swedish RMS provider Atomize to enhance Hospitality Cloud platform
Travel Tech
Nov 21, 2024
Preventive Healthcare

Preventive Healthcare

Mar 25, 2024

Midi Health partners with Neurotrack to screen for cognitive conditions in menopausal women

Partnerships

  • Women's health clinic Midi Health is collaborating with cognitive assessment firm Neurotrack to discern whether brain fog symptoms are related to menopause or early signs of dementia in women.

  • Through the partnership, Midi Health patients will gain access to a three-minute cognitive assessment by Neurotrack called the Symbol Match test, which can be taken online on any device. Midi Health clinicians can prescribe this test to their patients to distinguish between menopause-associated brain fog and more severe cognitive impairments like Alzheimer’s. Depending on test results, patients can either be referred to other services for cognitive conditions or treated for brain fog by their Midi Health clinician with diet adjustments, lifestyle changes, or medication.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.